Article Details
Retrieved on: 2024-07-10 14:43:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AEON Biopharma has taken proactive steps by setting up an initial biosimilar advisory meeting with the FDA, slated for early third quarter of 2024.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here